Abstract

AimsCytomegalovirus (CMV) infection under immunosuppression sometimes causes death. This study aimed to elucidate risk factors for CMV infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV).MethodsPatients with AAV who underwent remission induction treatment at Okayama University Hospital between 2006 and 2016 were retrospectively analyzed. The primary outcome was the development of CMV infection within 3 months.ResultsOf the 111 patients, 13 (11.7%) patients developed CMV infection. Patients with CMV infection were older (p = 0.030) and had a higher body mass index (p = 0.029) in comparison to those without CMV infection. A higher proportion had a severe form (p = 0.001) and granulomatosis with polyangiitis (GPA) (p = 0.001), as well as a higher Birmingham Vasculitis Activity Score (p = 0.018) and C-reactive protein (p = 0.018) levels at baseline. Using logistic regression analysis, severe form and GPA were independent risk factors (odds ratio [OR] = 9.68, 95% confidence interval [CI] = 1.92–60.23, and OR = 7.46, 95% CI = 1.46–47.60, respectively). In addition, patients with CMV infection were more likely than those without infection to be glucocorticoid-related diabetes mellitus (p = 0.025).ConclusionOur study highlights disease severity and subgroups of AAV as risk factors for CMV infection.

Highlights

  • The primary outcome was the development of CMV infection within 3 months

  • Severe form and granulomatosis with polyangiitis (GPA) were independent risk factors

  • Reviewer: 1 1.How many treated patients with associated vasculitis (AAV) were not tested for CMViraemia in the study period? What criteria were used for testing for CMViraemia?

Read more

Summary

Introduction

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis Manuscript Number: Article Type: Full Title: Short Title: Corresponding Author: Keywords: Abstract: Order of Authors: Opposed Reviewers: Response to Reviewers: PONE-D-18-20504R1 Risk factors for CMV infection in AAV patients Michiko Morishita "Okayama Daigaku Daigakuin Ishiyakugaku Sogo Kenkyuka Igakubu" Okayama, JAPAN

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.